Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2,617 $ 78,005,004 $ 636,886 $ (48,357,638) $ 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Comprehensive income (loss):          
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the financing, net of financing costs [1] $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (in Shares) [1] 2,564,000        
Offering costs allocated to warrant liabilities [2] 604,118 604,118
Offering costs allocated to warrant liabilities (in Shares) [2]        
Warrants issued in connection with private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809        
Stock based compensation:          
Common stock $ 20 925,384 925,404
Common stock (in Shares) 197,790        
Stock based compensation,Options 1,092,399 1,092,399
Comprehensive income (loss):          
Net income (loss) (16,198,585) (16,198,585)
Other comprehensive income (loss) 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Comprehensive income (loss):          
Net income (loss)         (21,360,865)
Shares issued to settle accounts payable         1,973,250
Balance at Sep. 30, 2021 $ 3,399 106,153,999 701,904 (69,718,503) 37,140,799
Balance (in Shares) at Sep. 30, 2021 33,968,735        
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Stock based compensation:          
Common stock $ 4 378,655 378,659
Common stock (in Shares) 37,515        
Stock based compensation,Options 344,095 344,095
Comprehensive income (loss):          
Net income (loss) (23,459,136) (23,459,136)
Other comprehensive income (loss) 406,487 406,487
Shares issued to settle accounts payable $ 23 1,973,227 1,973,250
Shares issued to settle accounts payable (in Shares) 225,000        
Impact of transfer agent reconciliation $ 28 (28)
Impact of transfer agent reconciliation (in Shares) 280,509        
Stock based compensation:          
Correction of an error 363,523 363,523
Balance at Jun. 30, 2021 $ 3,106 89,495,704 1,232,721 (88,015,359) 2,716,172
Balance (in Shares) at Jun. 30, 2021 31,061,354        
Comprehensive income (loss):          
Shares issued upon exchange of common stock equivalents $ 4 (4)
Shares issued upon exchange of common stock equivalents (in Shares) 44,240        
Stock based compensation:          
Common stock $ 8 431,988 431,996
Common stock (in Shares) 71,289        
Stock based compensation,Options 434,979 434,979
Comprehensive income (loss):          
Net income (loss) 18,296,856 18,296,856
Other comprehensive income (loss) (530,817) (530,817)
Comprehensive loss:          
Shares issued in connection with the August 2021 Offering, net of financing costs $ 250 13,879,750 13,880,000
Shares issued in connection with the August 2021 Offering, net of financing costs (in Shares) 2,500,000        
Shares issued to settle convertible det and derivative liabilities with Alpha Capital $ 15 1,060,485 1,060,500
Shares issued to settle convertible det and derivative liabilities with Alpha Capital (in Shares) 150,000        
Shares issued in connection with the repayment of related party loans and convertible notes $ 15 851,097 851,112
Shares issued in connection with the repayment of related party loans and convertible notes (in Shares) 141,852        
Balance at Sep. 30, 2021 $ 3,399 106,153,999 701,904 (69,718,503) 37,140,799
Balance (in Shares) at Sep. 30, 2021 33,968,735        
Balance at Dec. 31, 2021 $ 3,404 107,184,137 817,440 (68,682,286) 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925        
Shares issued for professional services to directors $ 5 149,713 149,718
Shares issued for professional services to directors (in Shares) 51,319        
Stock based compensation 596,467 596,467
Comprehensive income (loss):          
Net income (loss) 1,563,713 1,563,713
Other comprehensive income (loss) (728,081) (728,081)
Balance at Mar. 31, 2022 $ 3,409 107,930,317 89,359 (67,118,573) 40,904,512
Balance (in Shares) at Mar. 31, 2022 34,087,244        
Balance at Dec. 31, 2021 $ 3,404 107,184,137 817,440 (68,682,286) $ 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925        
Shares issued from exercise of pre-funded warrants (in Shares)        
Comprehensive income (loss):          
Net income (loss)         $ (16,983,981)
Shares issued to settle accounts payable        
Balance at Sep. 30, 2022 $ 3,924 115,427,474 (3,689,764) (85,666,267) 26,075,367
Balance (in Shares) at Sep. 30, 2022 39,246,011        
Balance at Mar. 31, 2022 $ 3,409 107,930,317 89,359 (67,118,573) 40,904,512
Balance (in Shares) at Mar. 31, 2022 34,087,244        
Shares issued for professional services to directors $ 4 60,623 60,627
Shares issued for professional services to directors (in Shares) 44,579        
Stock based compensation $ 1 795,051 795,052
Stock based compensation (in Shares) 12,000        
Comprehensive income (loss):          
Net income (loss) 2,939,284 2,939,284
Other comprehensive income (loss) (1,908,051) (1,908,051)
Balance at Jun. 30, 2022 $ 3,414 108,785,991 (1,818,692) (64,179,289) 42,791,424
Balance (in Shares) at Jun. 30, 2022 34,143,823        
Shares issued for professional services to directors $ 5 60,617 60,622
Shares issued for professional services to directors (in Shares) 55,112        
Issuance of pre-funded warrants [1] 2,562,265 2,562,265
Shares issued from exercise of pre-funded warrants [1] $ 155 155
Shares issued from exercise of pre-funded warrants (in Shares) [1] 1,547,076        
Shares issued in connection with July 2022 Offering [1] $ 350 3,407,140 3,407,490
Shares issued in connection with July 2022 Offering [1] 3,500,000        
Stock based compensation 611,461 611,461
Comprehensive income (loss):          
Net income (loss) (21,486,978) (21,486,978)
Other comprehensive income (loss) (1,871,072) (1,871,072)
Balance at Sep. 30, 2022 $ 3,924 $ 115,427,474 $ (3,689,764) $ (85,666,267) $ 26,075,367
Balance (in Shares) at Sep. 30, 2022 39,246,011        
[1] Consists of $6,499,737 of gross proceeds from the July 2022 Offering; gross proceeds of $3,710,000 are related to the common shares and common warrants issued and includes $302,510 in related placement agent fees and other offering costs, and $2,789,737 in gross proceeds are in connection with the pre-funded warrants and includes $227,472 in related placement agent fees and other offering costs. At the end of the period, 1,547,076 pre-funded warrants were exercised at an exercise price of $0.0001 for proceeds of $155.
[2] Consists of $11,666,200 of gross proceeds from the February 2021 PIPE offering, net of placement agent fees and other cash offering costs of $968,930. Of the $968,930 of offering costs, $364,812 was allocated to the common stock and $604,118 was allocated to the warrant liabilities and expensed immediately due to their liability classification.